Template:Ceftriaxone: Difference between revisions

Jump to navigation Jump to search
Abdurahman Khalil (talk | contribs)
No edit summary
Abdurahman Khalil (talk | contribs)
No edit summary
 
(One intermediate revision by the same user not shown)
Line 24: Line 24:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone clinical studies|Clinical Studies]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone direction for use |Direction For Use]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone Compatibility and Stability|Compatibility and Stability]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Ceftriaxone how supplied|How Supplied]]

Latest revision as of 18:42, 31 December 2013